Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
Objective To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone.
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Publishing Group Ltd.
2009
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728804/ |